NCT02842320View on ClinicalTrials.gov

Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 14, 2015

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Chronic Myeloid Leukemia
Interventions
OTHER

biological samples

bone marrow and blood

Trial Locations (4)

Unknown

Hôpital Nord Franche-Comté, Belfort

Centre Hospitalier Régional Universitaire de Besançon, Besançon

CHU de Dijon, Dijon

CHI de Haute-Saône, Vesoul

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02842320 - Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML) | Biotech Hunter | Biotech Hunter